cardiovascular benefits of glp 1 agonists Effects Glucagon-Like Peptide-1 Receptor GLP-1 receptor agonists and cardiovascular

Robert Weisman can be reached at [email protected]

Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections

There have also been documented local skin reactions when using GLP-1 RAs, particularly with the long-acting formulations

If youre considering compounded GLP-1s, make sure theyre true FDA-approved formulationsnot unstudied salt versions

Wegovy, based on semaglutide, is already one of the most influential GLP-1 drugs globally, supported by strong clinical evidence and widespread brand recognition

NAION occurs when blood flow to the optic nerve stops